Unlicensed Medicines – Managed Access
Insight Blog
20 Dec 2017
Early access to orphan medicines – a glimpse into the future
Unlicensed Medicines – Managed Access
Insight Blog
01 Dec 2017
Early Access to Orphan Medicines: Highlights from the World Orphan Drug Congress Barcelona, 2017
Unlicensed Medicines – Managed Access
Webinar
25 Jul 2017
Addressing Key Challenges Through Access to Unlicensed Medicines
Unlicensed Medicines – Managed Access
Insight Blog
10 Jul 2017
Busting 5 common myths around access to unlicensed medicines
Clinigen Consulting
Insight Blog
19 Jun 2017
21st Century Cures Act: Does a public expanded access policy actually mean improved access for patients?
Unlicensed Medicines – Global Access
Article
01 Jun 2017
Access to Unlicensed Medicines - EAHP 2017 Satellite Symposium Report
Clinigen Group
Insight Blog
02 May 2017
First journal to address the challenges of access to medicines
Clinical Trial Services
Insight Blog
17 Feb 2017
Investigator Initiated Trials: Supply strategies to add value and reduce burden
Clinigen Consulting
Article
17 Jan 2017
Managed Access Programmes: a powerful source of real-world insight
Unlicensed Medicines – Managed Access
Article
04 Jan 2017
Supplementing Clinical Development with a Managed Access Program